Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTH INVESTORS INCNHI · Entity 4125 | Director | September 27, 2024 | October 03, 2024 |
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director | May 02, 2025 | May 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTH INVESTORS INC
Report date September 27, 2024 · Filed October 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock by JMA Grandchildren's TrustSEC Table I · non-derivative | IndirectTrustee | 0 |
Reported balance
After 2024-09-27 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2024-09-27 · Other · Disposed 12,635 · Balance 0 F1: Mr. Adams serves as trustee of the JMA Grandchildren's Trust, of which his children are beneficiaries. On September 27, 2024, Mr. Adams, in his capacity as trustee, caused the trust to distribute 12,635 shares of NHI common stock to the trust's beneficiaries as part of his estate planning. The shares remain subject to a Lock-Up Agreement, which continues to apply to recipients of the stock. |
| Common Stock - Revocable Living TrustSEC Table I · non-derivative | IndirectTrustee | 708,469 |
Reported balance
Holding disclosure · report date 2024-09-27 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 708,469 |
| Common Stock By Adams Family Foundation IISEC Table I · non-derivative | IndirectTrustee | 177,000 |
Reported balance
Holding disclosure · report date 2024-09-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 177,000 |
| Common Stock by W. Andrew Adams Exempt TrustSEC Table I · non-derivative | Direct | 121,035 |
Reported balance
Holding disclosure · report date 2024-09-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 121,035 |
| Common Stock - held by SpouseSEC Table I · non-derivative | IndirectCommon Stock held by Spouse | 11,707 |
Reported balance
Holding disclosure · report date 2024-09-27 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 11,707 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Adams serves as trustee of the JMA Grandchildren's Trust, of which his children are beneficiaries. On September 27, 2024, Mr. Adams, in his capacity as trustee, caused the trust to distribute 12,635 shares of NHI common stock to the trust's beneficiaries as part of his estate planning. The shares remain subject to a Lock-Up Agreement, which continues to apply to recipients of the stock.
NATIONAL HEALTHCARE CORP
Report date May 02, 2025 · Filed May 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Shares of Common Stock - Revocable Living TrustSEC Table I · non-derivative | Direct | 269,572 |
Reported balance
After 2025-05-02 transaction · row 2
1 source rowRow 2 · 2025-05-02 · Exercise / conversion · Acquired 7,500 · Balance 269,572 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Option to Purchase Common Stock [2020 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $64.64 · Expires 2025-05-06 | Direct | 0 |
Reported balance
After 2025-05-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-05-02 · Exercise / conversion · Disposed 7,500 · Balance 0 F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| Shares of Common Stock - WAA Exempt TrustSEC Table I · non-derivative | Direct | 399,929 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 399,929 |
| Shares of Common Stock - Adams Family Foundation IISEC Table I · non-derivative | IndirectTrustee | 35,407 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 35,407 |
| Option to Purchase Common Stock [2021 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $71.64 · Expires 2026-05-05 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,500 |
| Option to Purchase Common Stock [2022 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $69.19 · Expires 2027-05-04 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 7,500 |
| Option to Purchase Common Stock [2023 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $55.75 · Expires 2028-05-02 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 7,500 |
| Option to Purchase Common Stock [2024 Grant]SEC Table II · derivative / convertible security · Conversion / exercise price $96.03 · Expires 2029-05-08 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2025-05-02 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 7,500 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2025 Filed May 6, 2025 17:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock [2020 Grant] · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-25-014829 · rdgdoc.xml · derivative · entry 4 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 02, 2025 Filed May 6, 2025 17:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Revocable Living Trust | 7,500 | $64.64 | $484,800.00 |
DisclosureSEC source: 0001437749-25-014829 · rdgdoc.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| September 27, 2024 Filed Oct 3, 2024 20:37 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | OtherCommon Stock by JMA Grandchildren's Trust | 12,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025129 · form4.xml · nonDerivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 0 F1 · kind: Mr. Adams serves as trustee of the JMA Grandchildren's Trust, of which his children are beneficiaries. On September 27, 2024, Mr. Adams, in his capacity as trustee, caused the trust to distribute 12,635 shares of NHI common stock to the trust's beneficiaries as part of his estate planning. The shares remain subject to a Lock-Up Agreement, which continues to apply to recipients of the stock. Read SEC document |
| September 27, 2024 Filed Oct 17, 2024 16:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | OtherShares of Common Stock - Adams Grandchildren's Trust | 2,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-031481 · rdgdoc.xml · nonDerivative · entry 4 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 0 F1 · shares: Mr. Adams serves as trustee of the Trust of which his children are beneficiaries. On September 27, 2024, Mr. Adams, in his capacity as trustee, caused the trust to distribute 2,307 shares of NHC common stock to the trust's beneficiaries as part of his estate planning. The shares remain subject to a Lock-Up Agreement, which continues to apply to recipients of the stock. Read SEC document |
| May 09, 2024 Filed May 13, 2024 17:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2024 Grant] · Derivative | 7,500 | $0.00 Strike: $96.03 | $0.00 |
DisclosureSEC source: 0001437749-24-016303 · rdgdoc.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-05-08 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 07, 2024 Filed May 9, 2024 18:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-24-015756 · rdgdoc.xml · derivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 07, 2024 Filed May 9, 2024 18:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - Revocable Living Trust | 7,500 | $77.92 | $584,400.00 |
DisclosureSEC source: 0001437749-24-015756 · rdgdoc.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 20:05 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Option (Right to Buy) 2024 · Derivative | 10,000 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-24-007065 · form4.xml · derivative · entry 6 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-02-23 Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 16:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | PurchaseShares of Common Stock - my name or my spouse's name | 1,861 | $67.17 | $125,000.95 |
DisclosureSEC source: 0001437749-23-023023 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,851 Read SEC document |
| May 04, 2023 Filed May 4, 2023 18:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2023 Grant] · Derivative | 7,500 | $0.00 Strike: $55.75 | $0.00 |
DisclosureSEC source: 0001437749-23-012632 · rdgdoc.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-05-03 F1 · shares: These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:23 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Option (Right to Buy) 2023 · Derivative | 10,000 | $0.00 Strike: $54.73 | $0.00 |
DisclosureSEC source: 0001127602-23-007606 · form4.xml · derivative · entry 13 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-02-24 Read SEC document |
| January 26, 2023 Filed Feb 14, 2024 22:09 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GiftCommon Stock By Amk, L.p. | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005069 · form5.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-029385 · rdgdoc.xml · derivative · entry 6 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-22-029385 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 13:59 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011298 · rdgdoc.xml · derivative · entry 11 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 19:52 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Option (Right to buy) 2022 · Derivative | 25,000 | $53.41 Strike: $53.41 | $1,335,250.00 |
DisclosureSEC source: 0001127602-22-007259 · form4.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-02-25 Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 20:01 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GiftCommon Stock By Adams Family Foundation II | 45,307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-021721 · form4.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trustee Disclosed balance after: 177,000 F1 · price: The reported transaction involves a transfer of securities by gift for which no payment of consideration was received by the reporting person. Read SEC document |
| May 27, 2021 Filed May 28, 2021 16:38 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-21-013741 · rdgdoc.xml · derivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 28, 2021 16:38 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 7,500 | $62.78 | $470,850.00 |
DisclosureSEC source: 0001437749-21-013741 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on June 2, 2016. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2021 Filed May 7, 2021 15:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $71.64 | $0.00 |
DisclosureSEC source: 0001437749-21-011326 · rdgdoc.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-05 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:54 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Options (Right to Buy) 2-25-2021 · Derivative | 25,000 | $0.00 Strike: $69.20 | $0.00 |
DisclosureSEC source: 0001127602-21-008391 · form4.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-02-25 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:18 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $60.52 | $0.00 |
DisclosureSEC source: 0001127602-21-007678 · form4.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:18 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Tax withholdingCommon Stock | 17,344 | $69.79 | $1,210,437.76 |
DisclosureSEC source: 0001127602-21-007678 · form4.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,169 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:18 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionCommon Stock | 20,000 | $60.52 | $1,210,400.00 |
DisclosureSEC source: 0001127602-21-007678 · form4.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 8, 2020 16:22 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-20-010071 · rdgdoc.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 30, 2020 Filed May 1, 2020 12:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,041 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-20-009105 · rdgdoc.xml · derivative · entry 7 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,459 Underlying: Common Stock · 7,500 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 1, 2020 12:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 2,041 | $61.25 | $125,011.25 |
DisclosureSEC source: 0001437749-20-009105 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| April 29, 2020 Filed May 1, 2020 12:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,459 | $0.00 Strike: $61.25 | $0.00 |
DisclosureSEC source: 0001437749-20-009105 · rdgdoc.xml · derivative · entry 8 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,459 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2020 Filed May 1, 2020 12:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock - my name or my spouse's name | 4,520 | $61.25 | $276,850.00 |
DisclosureSEC source: 0001437749-20-009105 · rdgdoc.xml · nonDerivative · entry 3 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,470 F2 · shares: Shares were withheld by the Company to pay the exercise price. F3 · balance_after: Total of the "Shares of Common Stock - my name or my spouse's name" security following transactions reported on this form. Read SEC document |
| April 29, 2020 Filed May 1, 2020 12:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 5,459 | $61.25 | $334,363.75 |
DisclosureSEC source: 0001437749-20-009105 · rdgdoc.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 7, 2015. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 21:57 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | PurchaseCommon Stock By Amk, L.p. | 27,000 | $36.16 | $976,320.00 |
DisclosureSEC source: 0001127602-20-011943 · form4.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,784 Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 23:57 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Options (Right to Buy) 2-21-2020 · Derivative | 25,000 | $90.79 Strike: $90.79 | $2,269,750.00 |
DisclosureSEC source: 0001127602-20-007715 · form4.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2025-02-21 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:41 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionStock Options (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $72.11 | $0.00 |
DisclosureSEC source: 0001127602-20-006089 · form4.xml · derivative · entry 11 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:41 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Tax withholdingCommon Stock | 16,274 | $88.62 | $1,442,201.88 |
DisclosureSEC source: 0001127602-20-006089 · form4.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,513 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:41 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionCommon Stock | 20,000 | $72.11 | $1,442,200.00 |
DisclosureSEC source: 0001127602-20-006089 · form4.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2019 Filed May 10, 2019 16:38 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $77.92 | $0.00 |
DisclosureSEC source: 0001437749-19-009492 · rdgdoc.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-05-08 F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 06, 2019 Filed May 8, 2019 12:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $52.93 | $0.00 |
DisclosureSEC source: 0001437749-19-009067 · rdgdoc.xml · derivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2019 Filed May 8, 2019 12:27 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 5,000 | $52.93 | $264,650.00 |
DisclosureSEC source: 0001437749-19-009067 · rdgdoc.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 8, 2014. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 21, 2019 Filed Feb 26, 2019 00:05 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Option Grant 2-21-19 · Derivative | 25,000 | $79.96 Strike: $79.96 | $1,999,000.00 |
DisclosureSEC source: 0001127602-19-008144 · form4.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-02-21 Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:33 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionStock Options (Right to Buy) 2-25-14 · Derivative | 15,000 | $0.00 Strike: $61.31 | $0.00 |
DisclosureSEC source: 0001127602-19-003201 · form4.xml · derivative · entry 11 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:33 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Tax withholdingCommon Stock | 11,322 | $81.23 | $919,686.06 |
DisclosureSEC source: 0001127602-19-003201 · form4.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:33 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | Exercise / conversionCommon Stock | 15,000 | $61.31 | $919,650.00 |
DisclosureSEC source: 0001127602-19-003201 · form4.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 12:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $52.93 | $0.00 |
DisclosureSEC source: 0001437749-18-022446 · rdgdoc.xml · derivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2019-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was amended November 8, 2018. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 12:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock - my name or my spouse's name | 2,500 | $52.93 | $132,325.00 |
DisclosureSEC source: 0001437749-18-022446 · rdgdoc.xml · nonDerivative · entry 2 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2005 Stock Option Plan on May 8, 2014. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 14 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $61.90 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 13 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 12 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $72.94 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 11 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 10 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 16:57 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Disposition to issuerOption to purchase common stock · Derivative | 7,500 | Not disclosed Strike: $62.78 | Not disclosed |
DisclosureSEC source: 0001437749-18-020609 · rdgdoc.xml · derivative · entry 9 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 F1 · kind: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · price: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.